|
1
|
McCarthy GM, Awde JD, Ghandi H, Vincent M
and Kocha WI: Risk factors associated with mucositis in cancer
patients receiving 5-fluorouracil. Oral Oncol. 34:484–490. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schirmer EM, Ferrari A and Trindade LCT:
Oral mucositis evolution after nutritional intervention in cancer
patients under palliative care. Rev Dor. 13:141–146. 2012.
View Article : Google Scholar
|
|
3
|
Sonis ST: New thoughts on the initiation
of mucositis. Oral Dis. 16:597–600. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lima V, Vidal FD, Rocha FA, Brito GA and
Ribeiro RA: Effects of tumor necrosis factor-alpha inhibitors
pentoxifylline and thalidomide on alveolar bone loss in short-term
experimental periodontal disease in rats. J Periodontol.
75:162–168. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mehta D and Malik AB: Signaling mechanisms
regulating endothelial permeability. Physiol Rev. 86:279–367. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lalla RV, Sonis ST and Peterson DE:
Management of oral mucositis in patients who have cancer. Dent Clin
North Am. 5261–77. (viii)2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sonis ST: Mucositis as a biological
process: a new hypothesis for the development of
chemotherapy-induced stomatotoxicity. Oral Oncol. 34:39–43. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu W, Zhang CC and Li K: Prognostic value
of chemotherapy-induced leukopenia in small-cell lung cancer.
Cancer Biol Med. 10:92–98. 2013.PubMed/NCBI
|
|
9
|
Sonis ST: The pathobiology of mucositis.
Nat Rev Cancer. 4:277–284. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stringer AM: Interaction between host
cells and microbes in chemotherapy-induced mucositis. Nutrients.
5:1488–1499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pinedo HM and Peters GF: Fluorouracil:
biochemistry and pharmacology. J Clin Oncol. 6:1653–1664.
1988.PubMed/NCBI
|
|
12
|
Alvarino-Martin C and Sarrion-Perez MG:
Prevention and treatment of oral mucositis in patients receiving
chemotherapy. J Clin Exp Dent. 6:e74–e80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Owlia F, Kazemeini SK and Gholami N:
Prevention and management of mucositis in patients with cancer: a
review article. Iranian J Cancer Prevent. 5:216–220. 2012.
|
|
14
|
Sonis S and Clark J: Prevention and
management of oral mucositis induced by antineoplastic therapy.
Oncology (Williston Park). 5:11–18; discussion 18–22.
1991.PubMed/NCBI
|
|
15
|
Sampaio EP, Moraes MO, Nery JA, Santos AR,
Matos HC and Sarno EN: Pentoxifylline decreases in vivo and in
vitro tumour necrosis factor-alpha (TNF-alpha) production in
lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Clin Exp Immunol. 111:300–308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Platzer C, Meisel C, Vogt K, Platzer M and
Volk HD: Up-regulation of monocytic IL-10 by tumor necrosis
factor-alpha and cAMP elevating drugs. Int Immunol. 7:517–523.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fujimoto T, Nakamura T, Furuya T, et al:
Relationship between the clinical efficacy of pentoxifylline
treatment and elevation of serum T helper type 2 cytokine levels in
patients with human T-lymphotropic virus type I-associated
myelopathy. Intern Med. 38:717–721. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gonzalez-Amaro R, Portales-Perez D,
Baranda L, et al: Pentoxifylline inhibits adhesion and activation
of human T lymphocytes. J Immunol. 161:65–72. 1998.PubMed/NCBI
|
|
19
|
Azevedo AM, Kumakura HS, Alloufa SL, et
al: Effect of simvastatin in attenuation of mucositis induced by
methotrexate in rats. J Surg Clin Res. 1:22–32. 2010.
|
|
20
|
Lea AP and McTavish D: Atorvastatin. A
review of its pharmacology and therapeutic potential in the
management of hyperlipidaemias. Drugs. 53:828–847. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Veillard NR and Mach F: Statins: the new
aspirin? Cell Mol Life Sci. 59:1771–1786. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ponomarev ED, Maresz K, Tan Y and Dittel
BN: CNS-derived interleukin-4 is essential for the regulation of
autoimmune inflammation and induces a state of alternative
activation in microglial cells. J Neurosci. 27:10714–10721. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weis M, Heeschen C, Glassford AJ and Cooke
JP: Statins have biphasic effects on angiogenesis. Circulation.
105:739–745. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dias DS, Fontes LB, Crotti AE, et al:
Copaiba oil suppresses inflammatory cytokines in splenocytes of
C57Bl/6 mice induced with experimental autoimmune encephalomyelitis
(EAE). Molecules. 19:12814–12826. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leandro LM, Vargas Fde S, Barbosa PC,
Neves JK, da Silva JA and da Veiga-Junior VF: Chemistry and
biological activities of terpenoids from copaiba (Copaifera spp.)
oleoresins. Molecules. 17:3866–3889. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vilanova C, Ribeiro SM, Machado R, et al:
Evaluation of oil-resin activity of Copaifera sp. on gastric
emptying in Rattus novergicus. Emirates J Food Agriculture.
25:394–397. 2013. View Article : Google Scholar
|
|
27
|
Dias DS, Fontes LBA, Crotti AEM, et al:
Copaiba Oil Suppresses Inflammatory Cytokines in Splenocytes of
C57Bl/6 Mice Induced with Experimental Autoimmune Encephalomyelitis
(EAE). Molecules. 19:12814–12826. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fernandes ES, Passos GF, Medeiros R, et
al: Anti-inflammatory effects of compounds alpha-humulene and
(–)-trans-caryophyllene isolated from the essential oil of Cordia
verbenacea. Eur J Pharmacol. 569:228–236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zargari O: Pentoxifylline: a drug with
wide spectrum applications in dermatology. Dermatol Online J.
14:22008.PubMed/NCBI
|
|
30
|
Sonis ST, Tracey C, Shklar G, Jenson J and
Florine D: An animal model for mucositis induced by cancer
chemotherapy. Oral Surg Oral Med Oral Pathol. 69:437–443. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lillie LE, Temple NJ and Florence LZ:
Reference values for young normal Sprague-Dawley rats: weight gain,
hematology and clinical chemistry. Hum Exp Toxicol. 15:612–616.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Correa JO, Aarestrup BJ and Aarestrup FM:
Effect of thalidomide and pentoxifylline on experimental autoimmune
encephalomyelitis (EAE). Exp Neurol. 226:15–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pinho-da-Silva L, Mendes-Maia PV, Teofilo
TM, et al: trans-Caryophyllene, a natural sesquiterpene, causes
tracheal smooth muscle relaxation through blockade of
voltage-dependent Ca2+ channels. Molecules.
17:11965–11977. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Medeiros CA, Leitao RF, Macedo RN, et al:
Effect of atorvastatin on 5-fluorouracil-induced experimental oral
mucositis. Cancer Chemother Pharmacol. 67:1085–1100. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He GX and Tan W: High-dose atorvastatin
pretreatment could diminish microvascular impairment in patients
undergoing elective percutaneous coronary intervention. J Geriatr
Cardiol. 10:355–360. 2013.PubMed/NCBI
|
|
36
|
Kose E, An T, Kikkawa A, Matsumoto Y and
Hayashi H: Effects on serum uric acid by difference of the renal
protective effects with atorvastatin and rosuvastatin in chronic
kidney disease patients. Biol Pharm Bull. 37:226–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu D, Cui W, Liu B, et al: Atorvastatin
protects vascular smooth muscle cells from TGF-β1-stimulated
calcification by inducing autophagy via suppression of the
β-catenin pathway. Cell Physiol Biochem. 33:129–141. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Su Q, Li L, Liu Y, Zhou Y, Wang J and Sun
Y: Effect of intensive atorvastatin therapy on periprocedural PDCD4
expression in CD4+ T lymphocytes of patients with
unstable angina undergoing percutaneous coronary intervention.
Cardiology. 127:169–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang W, Song W, Wang Y, Chen L and Yan X:
HMG-CoA reductase inhibitors, simvastatin and atorvastatin,
downregulate ABCG1-mediated cholesterol efflux in human
macrophages. J Cardiovasc Pharmacol. 62:90–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weber MS, Prod'homme T, Youssef S, Dunn
SE, Steinman L and Zamvil SS: Neither T-helper type 2 nor
Foxp3+ regulatory T cells are necessary for therapeutic
benefit of atorvastatin in treatment of central nervous system
autoimmunity. J Neuroinflammation. 11:292014. View Article : Google Scholar : PubMed/NCBI
|
